Antibiotic susceptibility of Listeria monocytogenes and treatment of neonatal listeriosis with ampicillin.
D000667:Ampicillin / Q000494:pharmacology / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002509:Cephaloridine / Q000494:pharmacology; D006801:Humans; D066298:In Vitro Techniques; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000188:drug therapy*; D007612:Kanamycin / Q000494:pharmacology; D008089:Listeria monocytogenes / Q000187:drug effects*; D008088:Listeriosis / Q000188:drug therapy*; D008297:Male; D010400:Penicillin G / Q000494:pharmacology; D010406:Penicillins / Q000494:pharmacology; D013307:Streptomycin / Q000494:pharmacology; D013411:Sulfadiazine / Q000494:pharmacology*; D013752:Tetracycline / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D010406:Penicillins; D013411:Sulfadiazine; D007612:Kanamycin; D000667:Ampicillin; D013752:Tetracycline; D002509:Cephaloridine; D010400:Penicillin G; D013307:Streptomycin